Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 04, 2016
3C! Packaging, an independent privately-owned pharmaceutical packaging solutions company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit dose applications, has received...
read more
Tuesday, January 06, 2015
3C! Packaging, an independent privately-owned pharmaceutical packaging solutions company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit dose applications, will begin ...
read more
Thursday, February 19, 2015
3C! Packaging, an independent privately-owned pharmaceutical packaging solutions company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit dose applications, will ...
read more
Wednesday, April 26, 2017
3D Systems and United Therapeutics Corporation announced plans to develop solid-organ scaffolds for human transplants.
read more
Wednesday, January 15, 2020
3D Systems and CollPlant Biotechnologies announced signing a joint development agreement intended to play a role in advancing and accelerating breakthroughs in the biomedical industry.
read more
3M Drug Delivery Systems U.K. organization is bringing its teams under one roof in Loughborough.
read more
Monday, December 16, 2019
3M has entered into an agreement to sell substantially all of its drug delivery business to an affiliate of Altaris Capital Partners.
read more
3P Biopharmaceuticals (3P) announced Keensight Capital as its new major investor.
read more
3P Biopharmaceuticals has signed a collaboration agreement with the Dutch biotech company Xenikos that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®.
read more
Thursday, December 27, 2018
3P Biopharmaceuticals has completed the project for the expansion and improvement of its facilities in Noáin (Spain) that had been carried out over the past months
read more
Friday, September 20, 2019
The FDA has classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized.
read more
What key topics will be discussed at the 3rd Anti-Counterfeiting for Pharmaceuticals?
read more
Medical device manufacturers hoping to enter the US market face increasing commercial competition and challenges to gain the funding necessary to support emerging brands. Because development and commercialization can consume a lot of resources, many...
read more
Thursday, August 27, 2026
4basebio and Genezen have expanded a non-exclusive collaboration intended to give cell and gene therapy developers access to synthetic, cell-free DNA for viral vector development and clinical programs.
read more
Monday, September 28, 2026
4basebio and TriLink BioTechnologies will provide DNA starting material and mRNA manufacturing services for an unnamed multinational pharmaceutical company’s planned Phase 1 cell therapy trial.
read more